Skip to main content
Equibles

CM Management, LLC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1841857 GULF BREEZE, FL
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$625,200
+$426,637 QoQ
Shares Held
60,000
+489.2% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#26
of 95 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CM Management, LLC holds $37,311,100 across 18 Biotechnology names. RNAC ranks #14 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RIGL
Rigel Pharmaceuticals Inc
 250,000 $9,780,000
2 RPRX
Royalty Pharma plc
 125,000 $7,008,750
3 CHRS
Coherus Oncology, Inc.
 2,100,000 $2,940,000
4 COYA
Coya Therapeutics, Inc.
 400,000 $2,340,000
5 ELDN
Eledon Pharmaceuticals, Inc.
 575,000 $2,265,500
6 LTRN
Lantern Pharma Inc.
 500,000 $2,085,000
7 IOVA
Iovance Biotherapeutics, Inc.
 450,000 $1,872,000
8 AVIR
Atea Pharmaceuticals, Inc.
 355,000 $1,650,750

All Filings in RNAC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $625,200 60,000
2024-03-31 $198,563 305,482
2023-12-31 $482,299 700,000
2023-09-30 $741,999 700,000
2023-06-30 $783,999 700,000
2023-03-31 $833,999 600,000
2022-12-31 $677,999 600,000
2022-09-30 $983,999 600,000
2022-06-30 $785,999 600,000
2022-03-31 $614,999 500,000
2021-12-31 $1,303,999 400,000
2021-09-30 $1,663,999 400,000
2021-06-30 $1,671,999 400,000
2021-03-31 $1,809,999 400,000
2020-12-31 $984,749 325,000